Open AccessThis article is
- freely available
Gene Therapy Strategies for HIV/AIDS: Preclinical Modeling in Humanized Mice
Department of Microbiology, Immunology and Pathology, Colorado State University, 1619 Campus delivery, Fort Collins, CO 80523, USA
* Author to whom correspondence should be addressed.
Received: 6 September 2013; in revised form: 4 November 2013 / Accepted: 3 December 2013 / Published: 12 December 2013
Abstract: In the absence of an effective vaccine and lack of a complete cure, gene therapy approaches to control HIV infection offer feasible alternatives. Due to the chronic nature of infection, a wide window of opportunity exists to gene modify the HIV susceptible cells that continuously arise from the bone marrow source. To evaluate promising gene therapy approaches that employ various anti-HIV therapeutic molecules, an ideal animal model is necessary to generate important efficacy and preclinical data. In this regard, the humanized mouse models that harbor human hematopoietic cells susceptible to HIV infection provide a suitable in vivo system. This review summarizes the currently used humanized mouse models and different anti-HIV molecules utilized for conferring HIV resistance. Humanized mouse models are compared for their utility in this context and provide perspectives for new directions.
Keywords: gene therapy for HIV/AIDS; humanized mice for HIV gene therapy; stem cell-based gene therapy; anti-HIV RNA-based therapies; new generation humanized mice
Citations to this Article
Cite This Article
MDPI and ACS Style
Bennett, M.S.; Akkina, R. Gene Therapy Strategies for HIV/AIDS: Preclinical Modeling in Humanized Mice. Viruses 2013, 5, 3119-3141.
Bennett MS, Akkina R. Gene Therapy Strategies for HIV/AIDS: Preclinical Modeling in Humanized Mice. Viruses. 2013; 5(12):3119-3141.
Bennett, Michael S.; Akkina, Ramesh. 2013. "Gene Therapy Strategies for HIV/AIDS: Preclinical Modeling in Humanized Mice." Viruses 5, no. 12: 3119-3141.